Among the common features shared by neurodegenerative diseases there is the central role played by specific proteins or peptides which accumulate in neurons as insoluble plaques or tangles, containing abnormal amounts of redox-active metal ions, like copper and iron. In the case of transmissible spongiform encephalopathies (TSE), the involved protein is known as “prion protein” (PrPC) since “prions” (proteinaceous and infectious) are the agents which make TSE transmissible. It is widely accepted that PrPC, in its wild-type form, can bind up to six CuII ions, four of them in the so-called “octarepeat domain” and the others in the “fifth (non-octarepeat) binding-site”. The latter domain contains two His residues, acting as anchoring sites for CuII ions, and other potential binding residues, such as Lys and Met. While it is widely accepted that Lys residues do not take part in complex-formation, the role of methionines is still debated. In order to shed light on this issue, some peptides have been synthesized, either directly mimicking the sequence of the second half of the fifth binding site of human-PrPC (apo-form) or analogues where Met residues have been substituted by n-leucine. In addition, a series of short peptides, containing both His and Met residues in different relative positions, have been investigated, for the sake of comparison. Spectroscopic results, including NMR spectra of systems containing NiII as a probe for the paramagnetic CuII ion, agree on the exclusion of any direct interaction between the sulphur atom of Met residues and the CuII ion already bound to His-imidazole side-chains. However, thermodynamic data show that Met-109 somewhat contributes to stability of complex species and this can be attributed to different electronic and steric effects.